Mexico, Belize, and Costa Rica are among the few Americas countries reporting small increases in Zika virus activity, the Pan American Health Organization (PAHO) said in its Aug 25 epidemiologic update.
Though coverage still isn't optimal, for the first time rates topped 60%, with the boys' level gaining ground on the girls'.
Researchers in New Zealand report today in The Lancet that exposure to the outer-membrane vesical meningococcal B vaccine (MeNZB) was associated with reduced rates of gonorrhea in a retrospective case-control study. It's the first time a vaccine has shown any protection against the sexually transmitted infection.
According to the latest numbers from the Centers for Disease Control and Prevention (CDC), there are now 88 babies born in the United States with Zika-related birth defects, an increase of 8 since the last report. The number of pregnancy losses showing Zika-related birth defects remains at 8.
The cluster has been classified as a meningococcal C outbreak, but a cofactor may be involved.
In the wake of new laws and tighter federal oversight, the FDA has done more than 400 inspections, sent 150 warning letters, and overseen 125 recalls.
In the latest situation report on the current Ebola outbreak in the Democratic Republic of the Congo (DRC), the World Health Organization (WHO) said that international vaccine deployment of rVSV-ZEBOV, the experimental Ebola vaccine, and cold chain shipment is not advised at this time to contain the outbreak.
According to the latest World Health Organization (WHO) situation report, there are now 43 suspected cases of Ebola in the Democratic Republic of the Congo (DRC). This is six more probable cases since the last situation report released yesterday.
A multicenter study of patients with MRSA bloodstream infections caused by a community-associated strain of the pathogen has identified race as a primary association, researchers reported yesterday in the Journal of Infectious Diseases.
The US Centers for Disease Control and Prevention said yesterday that the positive test results for Neisseria meningitidis from four Liberian patients is serotype C, Science reported yesterday. Kai Kupferschmidt, the author of the Science report, said on Twitter today that the tests were on blood and that testing is under way on cerebrospinal fluid samples.